BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bhatti I, Peacock O, Lloyd G, Larvin M, Hall RI. Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. Am J Surg. 2010;200:197-203. [PMID: 20122680 DOI: 10.1016/j.amjsurg.2009.08.041] [Cited by in Crossref: 197] [Cited by in F6Publishing: 217] [Article Influence: 16.4] [Reference Citation Analysis]
Number Citing Articles
1 Chang CF, Huang PW, Chen JS, Chen YY, Lu CH, Chang PH, Hung YS, Chou WC. Prognostic Factors for Advanced Pancreatic Cancer Treated with Gemcitabine Plus S-1: Retrospective Analysis and Development of a Prognostic Model. Cancers (Basel) 2019;11:E57. [PMID: 30634387 DOI: 10.3390/cancers11010057] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
2 Solaini L, Atmaja BT, Watt J, Arumugam P, Hutchins RR, Abraham AT, Bhattacharya S, Kocher HM. Limited utility of inflammatory markers in the early detection of postoperative inflammatory complications after pancreatic resection: Cohort study and meta-analyses. Int J Surg. 2015;17:41-47. [PMID: 25779213 DOI: 10.1016/j.ijsu.2015.03.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
3 Iwai N, Okuda T, Sakagami J, Harada T, Ohara T, Taniguchi M, Sakai H, Oka K, Hara T, Tsuji T, Komaki T, Kagawa K, Yasuda H, Naito Y, Itoh Y. Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancer. Sci Rep 2020;10:18758. [PMID: 33127996 DOI: 10.1038/s41598-020-75745-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
4 Mitsuya K, Nakasu Y, Kurakane T, Hayashi N, Harada H, Nozaki K. Elevated preoperative neutrophil-to-lymphocyte ratio as a predictor of worse survival after resection in patients with brain metastasis. J Neurosurg 2017;127:433-7. [PMID: 27911233 DOI: 10.3171/2016.8.JNS16899] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
5 Templeton AJ, McNamara MG, Šeruga B, Vera-Badillo FE, Aneja P, Ocaña A, Leibowitz-Amit R, Sonpavde G, Knox JJ, Tran B, Tannock IF, Amir E. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 2014;106:dju124. [PMID: 24875653 DOI: 10.1093/jnci/dju124] [Cited by in Crossref: 1177] [Cited by in F6Publishing: 1247] [Article Influence: 147.1] [Reference Citation Analysis]
6 Shi J, Zhao W, Ying H, Du J, Chen J, Chen S, Shen B. The relationship of platelet to lymphocyte ratio and neutrophil to monocyte ratio to radiographic grades of knee osteoarthritis. Z Rheumatol 2018;77:533-7. [PMID: 28681116 DOI: 10.1007/s00393-017-0348-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
7 Jung J, Park SY, Park S, Park J. Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinoma. Tumor Biol 2016;37:7149-54. [DOI: 10.1007/s13277-015-4596-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
8 Demirci NS, Erdem GU. Prognostic role of neutrophil-to-lymphocyte ratio (NLR) in patients with operable ampullary carcinoma. Bosn J Basic Med Sci 2018;18:268-74. [PMID: 29131967 DOI: 10.17305/bjbms.2017.2530] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Şefik E, Günlüsoy B, Aydoğdu Ö, Topçu YK, Ceylan Y, Değirmenci T, Dinçel Ç. Predictive role of neutrophil-to-lymphocyte ratio on upstaging of organ-confined invasive urothelial bladder cancer to non-organ-confined disease. Turk J Urol 2018;44:119-24. [PMID: 29511580 DOI: 10.5152/tud.2017.46038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Spolverato G, Maqsood H, Kim Y, Margonis G, Luo T, Ejaz A, Pawlik TM. Neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after resection for hepato-pancreatico-biliary malignancies. J Surg Oncol 2015;111:868-74. [PMID: 25865111 DOI: 10.1002/jso.23900] [Cited by in Crossref: 30] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
11 Wang D, Yang JX, Cao DY, Wan XR, Feng FZ, Huang HF, Shen K, Xiang Y. Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma. Onco Targets Ther 2013;6:211-6. [PMID: 23525143 DOI: 10.2147/OTT.S41711] [Cited by in Crossref: 11] [Cited by in F6Publishing: 38] [Article Influence: 1.2] [Reference Citation Analysis]
12 Hu CL, Du QC, Wang ZX, Pang MQ, Wang YY, Li YY, Zhou Y, Wang HJ, Fan HN. Relationship between platelet-based models and the prognosis of patients with malignant hepatic tumors. Oncol Lett 2020;19:2384-96. [PMID: 32194738 DOI: 10.3892/ol.2020.11317] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Huang GQ, Zhu GQ, Liu YL, Wang LR, Braddock M, Zheng MH, Zhou MT. Stratified neutrophil-to-lymphocyte ratio accurately predict mortality risk in hepatocellular carcinoma patients following curative liver resection. Oncotarget. 2016;7:5429-5439. [PMID: 26716411 DOI: 10.18632/oncotarget.6707] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
14 Schlick K, Magnes T, Huemer F, Ratzinger L, Weiss L, Pichler M, Melchardt T, Greil R, Egle A. C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling overall survival Prediction in Pancreatic Cancer Patients. J Clin Med. 2019;8. [PMID: 31717722 DOI: 10.3390/jcm8111791] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
15 Tsujita E, Ikeda Y, Kinjo N, Yamashita Y, Hisano T, Furukawa M, Taguchi K, Morita M, Toh Y, Okamura T. Postoperative Neutrophil-to-Lymphocyte Ratio as a Predictor of Long-Term Prognosis after Pancreatectomy for Pancreatic Carcinoma: A Retrospective Analysis. The American Surgeon 2017;83:610-6. [DOI: 10.1177/000313481708300626] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
16 Lee BM, Chung SY, Chang JS, Lee KJ, Seong J. The Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Are Prognostic Factors in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiotherapy. Gut Liver 2018;12:342-52. [PMID: 29409306 DOI: 10.5009/gnl17216] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
17 Li X, Han Z, Cheng Z, Yu J, Liu S, Yu X, Liang P. Preoperative neutrophil-to-lymphocyte ratio is a predictor of recurrence following thermal ablation for recurrent hepatocellular carcinoma: a retrospective analysis. PLoS One 2014;9:e110546. [PMID: 25330319 DOI: 10.1371/journal.pone.0110546] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
18 Jiang N, Deng JY, Liu Y, Ke B, Liu HG, Liang H. The role of preoperative neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after radical resection for gastric cancer. Biomarkers 2014;19:444-51. [PMID: 24910346 DOI: 10.3109/1354750X.2014.926567] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
19 He JR, Shen GP, Ren ZF, Qin H, Cui C, Zhang Y, Zeng YX, Jia WH. Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma. Head Neck 2012;34:1769-76. [PMID: 22318781 DOI: 10.1002/hed.22008] [Cited by in Crossref: 118] [Cited by in F6Publishing: 124] [Article Influence: 11.8] [Reference Citation Analysis]
20 Feng JF, Huang Y, Liu JS. Combination of neutrophil lymphocyte ratio and platelet lymphocyte ratio is a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma. Onco Targets Ther. 2013;6:1605-1612. [PMID: 24403837 DOI: 10.2147/ott.s52501] [Cited by in Crossref: 11] [Cited by in F6Publishing: 39] [Article Influence: 1.2] [Reference Citation Analysis]
21 Miyamoto R, Oda T, Hashimoto S, Kurokawa T, Kohno K, Akashi Y, Ohara Y, Yamada K, Enomoto T, Ohkohchi N. Platelet × CRP Multiplier Value as an Indicator of Poor Prognosis in Patients With Resectable Pancreatic Cancer. Pancreas 2017;46:35-41. [DOI: 10.1097/mpa.0000000000000697] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
22 Ye S, Bai L. Comparison and validation of the value of preoperative inflammation marker-based prognostic scores in resectable pancreatic ductal adenocarcinoma. Cancer Manag Res 2018;10:3405-17. [PMID: 30237742 DOI: 10.2147/CMAR.S173444] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
23 Brito GMC, Fontenele AMM, Carneiro ECRL, Nogueira IAL, Cavalcante TB, Vale AAM, Monteiro SCM, Salgado Filho N. Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Nondialysis Chronic Kidney Patients. Int J Inflam 2021;2021:6678960. [PMID: 34257898 DOI: 10.1155/2021/6678960] [Reference Citation Analysis]
24 Medrano J, Garnier J, Ewald J, Marchese U, Gilabert M, Launay S, Poizat F, Giovannini M, Delpero JR, Turrini O. Patient outcome according to the 2017 international consensus on the definition of borderline resectable pancreatic ductal adenocarcinoma. Pancreatology. 2020;20:223-228. [PMID: 31839458 DOI: 10.1016/j.pan.2019.12.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
25 Hirahara N, Fujii Y, Yamamoto T, Hyakudomi R, Hirayama T, Taniura T, Ishitobi K, Tajima Y. Validation of a novel prognostic scoring system using inflammatory response biomarkers in patients undergoing curative thoracoscopic esophagectomy for esophageal squamous cell carcinoma. Onco Targets Ther 2017;10:363-70. [PMID: 28144151 DOI: 10.2147/OTT.S124556] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Miglani RK, Bhateja N, Bhat RS, Kumar KV. Diagnostic Role of Platelet Lymphocyte Ratio(PLR) in Pancreatic Head Masses. Indian J Surg 2013;75:4-9. [PMID: 24426375 DOI: 10.1007/s12262-012-0443-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
27 Stevens L, Pathak S, Nunes QM, Pandanaboyana S, Macutkiewicz C, Smart N, Smith AM. Prognostic significance of pre-operative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreatic cancer: a systematic review. HPB (Oxford) 2015;17:285-91. [PMID: 25431369 DOI: 10.1111/hpb.12355] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 6.8] [Reference Citation Analysis]
28 Perisanidis C, Kornek G, Pöschl PW, Holzinger D, Pirklbauer K, Schopper C, Ewers R. High neutrophil-to-lymphocyte ratio is an independent marker of poor disease-specific survival in patients with oral cancer. Med Oncol 2013;30. [DOI: 10.1007/s12032-012-0334-5] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 7.3] [Reference Citation Analysis]
29 Takeda T, Takeuchi M, Saitoh M, Takeda S. Neutrophil-to-lymphocyte ratio after four weeks of nivolumab administration as a predictive marker in patients with pretreated non-small-cell lung cancer. Thorac Cancer 2018;9:1291-9. [PMID: 30126063 DOI: 10.1111/1759-7714.12838] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 6.3] [Reference Citation Analysis]
30 Garcea G, Cairns V, Berry DP, Neal CP, Metcalfe MS, Dennison AR. Improving the diagnostic yield from staging laparoscopy for periampullary malignancies: the value of preoperative inflammatory markers and radiological tumor size. Pancreas 2012;41:233-7. [PMID: 21946812 DOI: 10.1097/MPA.0b013e31822432ee] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
31 Pinato DJ, Mauri FA, Ramakrishnan R, Wahab L, Lloyd T, Sharma R. Inflammation-based prognostic indices in malignant pleural mesothelioma. J Thorac Oncol 2012;7:587-94. [PMID: 22307011 DOI: 10.1097/JTO.0b013e31823f45c1] [Cited by in Crossref: 82] [Cited by in F6Publishing: 50] [Article Influence: 8.2] [Reference Citation Analysis]
32 Cheng H, Long F, Jaiswar M, Yang L, Wang C, Zhou Z. Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: a meta-analysis. Sci Rep 2015;5:11026. [PMID: 26226887 DOI: 10.1038/srep11026] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 7.7] [Reference Citation Analysis]
33 Miura T, Hirano S, Nakamura T, Tanaka E, Shichinohe T, Tsuchikawa T, Kato K, Matsumoto J, Kondo S. A new preoperative prognostic scoring system to predict prognosis in patients with locally advanced pancreatic body cancer who undergo distal pancreatectomy with en bloc celiac axis resection: A retrospective cohort study. Surgery 2014;155:457-67. [DOI: 10.1016/j.surg.2013.10.024] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
34 Sunbul M, Gerin F, Durmus E, Kivrak T, Sari I, Tigen K, Cincin A. Neutrophil to lymphocyte and platelet to lymphocyte ratio in patients with dipper versus non-dipper hypertension. Clin Exp Hypertens. 2014;36:217-221. [PMID: 23786430 DOI: 10.3109/10641963.2013.804547] [Cited by in Crossref: 84] [Cited by in F6Publishing: 84] [Article Influence: 9.3] [Reference Citation Analysis]
35 Galdiero MR, Varricchi G, Marone G. The immune network in thyroid cancer. Oncoimmunology 2016;5:e1168556. [PMID: 27471646 DOI: 10.1080/2162402X.2016.1168556] [Cited by in Crossref: 49] [Cited by in F6Publishing: 31] [Article Influence: 8.2] [Reference Citation Analysis]
36 Li Y, Li H, Li W, Wang L, Yan Z, Yao Y, Yao R, Xu K, Li Z. Pretreatment neutrophil/lymphocyte ratio but not platelet/lymphocyte ratio has a prognostic impact in multiple myeloma. J Clin Lab Anal 2017;31. [PMID: 27925303 DOI: 10.1002/jcla.22107] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
37 Wang H, Ding Y, Li N, Wu L, Gao Y, Xiao C, Jiang H, Zheng Y, Mao C, Deng J, Wang H, Xu N. Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Combined Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Stage IV Advanced Gastric Cancer. Front Oncol 2020;10:841. [PMID: 32637353 DOI: 10.3389/fonc.2020.00841] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
38 Luo G, Liu C, Cheng H, Jin K, Guo M, Lu Y, Long J, Xu J, Ni Q, Chen J, Yu X. Neutrophil-lymphocyte ratio predicts survival in pancreatic neuroendocrine tumors. Oncol Lett 2017;13:2454-8. [PMID: 28454419 DOI: 10.3892/ol.2017.5716] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
39 McIntyre CA, Pulvirenti A, Lawrence SA, Seier K, Gonen M, Balachandran VP, Kingham TP, DʼAngelica MI, Drebin JA, Jarnagin WR, Allen PJ. Neutrophil-to-Lymphocyte Ratio as a Predictor of Invasive Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas. Pancreas 2019;48:832-6. [PMID: 31210665 DOI: 10.1097/MPA.0000000000001342] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
40 Rodríguez-Rodríguez E, López-Sobaler AM, Ortega RM, Delgado-Losada ML, López-Parra AM, Aparicio A. Association between Neutrophil-to-Lymphocyte Ratio with Abdominal Obesity and Healthy Eating Index in a Representative Older Spanish Population. Nutrients 2020;12:E855. [PMID: 32210070 DOI: 10.3390/nu12030855] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
41 Watanabe J, Otani S, Sakamoto T, Arai Y, Hanaki T, Amisaki M, Tokuyasu N, Honjo S, Ikeguchi M. Prognostic indicators based on inflammatory and nutritional factors after pancreaticoduodenectomy for pancreatic cancer. Surg Today 2016;46:1258-67. [DOI: 10.1007/s00595-016-1308-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 6.7] [Reference Citation Analysis]
42 Shaverdian N, Veruttipong D, Wang J, Schaue D, Kupelian P, Lee P. Pretreatment Immune Parameters Predict for Overall Survival and Toxicity in Early-Stage Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy. Clin Lung Cancer 2016;17:39-46. [PMID: 26372098 DOI: 10.1016/j.cllc.2015.07.007] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 5.3] [Reference Citation Analysis]
43 Kawashita Y, Kitamura M, Soutome S, Ukai T, Umeda M, Saito T. Association of neutrophil-to-lymphocyte ratio with severe radiation-induced mucositis in pharyngeal or laryngeal cancer patients: a retrospective study. BMC Cancer 2021;21:1064. [PMID: 34583669 DOI: 10.1186/s12885-021-08793-6] [Reference Citation Analysis]
44 Huguet E, Maccallini G, Pardini P, Hidalgo M, Obregon S, Botto F, Koretzky M, Nilsson PM, Ferdinand K, Kotliar C. Reference Values for Neutrophil to Lymphocyte Ratio (NLR), a Biomarker of Cardiovascular Risk, According to Age and Sex in a Latin American Population. Curr Probl Cardiol 2021;46:100422. [PMID: 31103219 DOI: 10.1016/j.cpcardiol.2019.04.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
45 Noh H, Eomm M, Han A. Usefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patients. J Breast Cancer 2013;16:55-9. [PMID: 23593082 DOI: 10.4048/jbc.2013.16.1.55] [Cited by in Crossref: 106] [Cited by in F6Publishing: 112] [Article Influence: 11.8] [Reference Citation Analysis]
46 Białas AJ, Pedone C, Piotrowski WJ, Antonelli Incalzi R. Platelet distribution width as a prognostic factor in patients with COPD - pilot study. Int J Chron Obstruct Pulmon Dis 2017;12:2261-7. [PMID: 28814854 DOI: 10.2147/COPD.S131868] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
47 So YK, Lee G, Oh D, Byeon S, Park W, Chung MK. Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Patients with Human Papillomavirus-Positive Oropharyngeal Cancer. Otolaryngol Head Neck Surg 2018;159:303-9. [PMID: 29557259 DOI: 10.1177/0194599818764651] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
48 Ogura Y, Kataoka N, Kunimatsu Y, Tachibana Y, Sugimoto T, Tani N, Sato I, Hirose K, Kato D, Takeda T. Predictors of survival among Japanese patients receiving first-line chemoimmunotherapy for advanced non-small cell lung cancer. Thorac Cancer 2021;12:97-105. [PMID: 33124197 DOI: 10.1111/1759-7714.13720] [Reference Citation Analysis]
49 Haddad CR, Guo L, Clarke S, Guminski A, Back M, Eade T. Neutrophil-to-lymphocyte ratio in head and neck cancer. J Med Imaging Radiat Oncol 2015;59:514-9. [PMID: 25908427 DOI: 10.1111/1754-9485.12305] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
50 Rochefort P, Lardy-Cleaud A, Sarabi M, Desseigne F, Cattey-Javouhey A, de la Fouchardière C. Long-Term Survivors in Metastatic Pancreatic Ductal Adenocarcinoma: A Retrospective and Matched Pair Analysis. Oncologist 2019;24:1543-8. [PMID: 31164454 DOI: 10.1634/theoncologist.2018-0786] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
51 Raungkaewmanee S, Tangjitgamol S, Manusirivithaya S, Srijaipracharoen S, Thavaramara T. Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer. J Gynecol Oncol. 2012;23:265-273. [PMID: 23094130 DOI: 10.3802/jgo.2012.23.4.265] [Cited by in Crossref: 133] [Cited by in F6Publishing: 127] [Article Influence: 13.3] [Reference Citation Analysis]
52 Durmus E, Kivrak T, Gerin F, Sunbul M, Sari I, Erdogan O. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio are Predictors of Heart Failure. Arq Bras Cardiol 2015;105:606-13. [PMID: 26536980 DOI: 10.5935/abc.20150126] [Cited by in Crossref: 16] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
53 Galdiero MR, Varricchi G, Loffredo S, Bellevicine C, Lansione T, Ferrara AL, Iannone R, di Somma S, Borriello F, Clery E, Triassi M, Troncone G, Marone G. Potential involvement of neutrophils in human thyroid cancer. PLoS One 2018;13:e0199740. [PMID: 29953504 DOI: 10.1371/journal.pone.0199740] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
54 Graupp M, Schaffer K, Wolf A, Vasicek S, Weiland T, Pondorfer P, Holzmeister C, Moser U, Thurnher D. C-reactive protein is an independent prognostic marker in patients with tongue carcinoma - A retrospective study. Clin Otolaryngol 2018;43:1050-6. [PMID: 29575651 DOI: 10.1111/coa.13102] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
55 Ahmad J, Grimes N, Farid S, Morris-Stiff G. Inflammatory response related scoring systems in assessing the prognosis of patients with pancreatic ductal adenocarcinoma: a systematic review. Hepatobiliary Pancreat Dis Int 2014;13:474-81. [PMID: 25308357 DOI: 10.1016/s1499-3872(14)60284-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
56 Fang H, Huang XY, Chien H, Chang JT, Liao C, Huang J, Wei F, Wang H, Chen I, Kang C, Huang S. Refining the role of preoperative C-reactive protein by neutrophil/lymphocyte ratio in oral cavity squamous cell carcinoma: CRP and NLR in OSCC. The Laryngoscope 2013;123:2690-9. [DOI: 10.1002/lary.24105] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 5.8] [Reference Citation Analysis]
57 Swierczak A, Mouchemore KA, Hamilton JA, Anderson RL. Neutrophils: important contributors to tumor progression and metastasis. Cancer Metastasis Rev 2015;34:735-51. [DOI: 10.1007/s10555-015-9594-9] [Cited by in Crossref: 83] [Cited by in F6Publishing: 86] [Article Influence: 11.9] [Reference Citation Analysis]
58 Feng JF, Huang Y, Chen QX. Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma. World J Surg Oncol 2014;12:58. [PMID: 24641770 DOI: 10.1186/1477-7819-12-58] [Cited by in Crossref: 125] [Cited by in F6Publishing: 139] [Article Influence: 15.6] [Reference Citation Analysis]
59 Topkan E, Mertsoylu H, Ozdemir Y, Sezer A, Kucuk A, Besen AA, Ozyilkan O, Selek U. Prognostic Usefulness Of Advanced Lung Cancer Inflammation Index In Locally-Advanced Pancreatic Carcinoma Patients Treated With Radical Chemoradiotherapy. Cancer Manag Res 2019;11:8807-15. [PMID: 31632140 DOI: 10.2147/CMAR.S222297] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
60 Seretis C, Seretis F, Lagoudianakis E, Politou M, Gemenetzis G, Salemis NS. Enhancing the accuracy of platelet to lymphocyte ratio after adjustment for large platelet count: a pilot study in breast cancer patients. Int J Surg Oncol 2012;2012:653608. [PMID: 23304480 DOI: 10.1155/2012/653608] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 0.2] [Reference Citation Analysis]
61 Gao HY, Zhang H, Xu XD, Zou WB, Lin KL, Deng YC, Liu QQ, Jiang JX, Wang M, Zhu F, Qin RY. Neutrophil-lymphocyte ratio as a prognostic factor for gallbladder carcinoma after radical resection. Shijie Huaren Xiaohua Zazhi 2015; 23(35): 5705-5710 [DOI: 10.11569/wcjd.v23.i35.5705] [Cited by in CrossRef: 2] [Article Influence: 0.3] [Reference Citation Analysis]
62 Li X, Han Z, Cheng Z, Yu J, Yu X, Liang P. Clinical significance of preoperative platelet-to-lymphocyte ratio in recurrent hepatocellular carcinoma after thermal ablation: A retrospective analysis. International Journal of Hyperthermia 2015;31:758-63. [DOI: 10.3109/02656736.2015.1068958] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
63 Ou Q, Cheng J, Zhang L, Wang H, Wang W, Ma Y. The prognostic value of pretreatment neutrophil-to-lymphocyte ratio in breast cancer: Deleterious or advantageous? Tumour Biol 2017;39:1010428317706214. [PMID: 28653873 DOI: 10.1177/1010428317706214] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
64 Luo G, Guo M, Liu Z, Xiao Z, Jin K, Long J, Liu L, Liu C, Xu J, Ni Q, Yu X. Blood neutrophil-lymphocyte ratio predicts survival in patients with advanced pancreatic cancer treated with chemotherapy. Ann Surg Oncol. 2015;22:670-676. [PMID: 25155401 DOI: 10.1245/s10434-014-4021-y] [Cited by in Crossref: 86] [Cited by in F6Publishing: 94] [Article Influence: 10.8] [Reference Citation Analysis]
65 Garcea G, Ladwa N, Neal CP, Metcalfe MS, Dennison AR, Berry DP. Preoperative neutrophil-to-lymphocyte ratio (NLR) is associated with reduced disease-free survival following curative resection of pancreatic adenocarcinoma. World J Surg. 2011;35:868-872. [PMID: 21312035 DOI: 10.1007/s00268-011-0984-z] [Cited by in Crossref: 133] [Cited by in F6Publishing: 132] [Article Influence: 12.1] [Reference Citation Analysis]
66 Inman KS, Francis AA, Murray NR. Complex role for the immune system in initiation and progression of pancreatic cancer. World J Gastroenterol 2014; 20(32): 11160-11181 [PMID: 25170202 DOI: 10.3748/wjg.v20.i32.11160] [Cited by in CrossRef: 73] [Cited by in F6Publishing: 78] [Article Influence: 9.1] [Reference Citation Analysis]
67 Vasquez L, León E, Beltran B, Maza I, Oscanoa M, Geronimo J. Pretreatment Neutrophil-to-Lymphocyte Ratio and Lymphocyte Recovery: Independent Prognostic Factors for Survival in Pediatric Sarcomas. J Pediatr Hematol Oncol 2017;39:538-46. [PMID: 28697168 DOI: 10.1097/MPH.0000000000000911] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
68 Park JS, Kim HM, Jeung HC, Kang SA. Association between early nutritional risk and overall survival in patients with advanced pancreatic cancer: A single-center retrospective study. Clin Nutr ESPEN 2019;30:94-9. [PMID: 30904235 DOI: 10.1016/j.clnesp.2019.01.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
69 Kim JY, Park T, Jeong SH, Jeong CY, Ju YT, Lee YJ, Hong SC, Ha WS, Choi SK, Jung EJ. Prognostic importance of baseline neutrophil to lymphocyte ratio in patients with advanced papillary thyroid carcinomas. Endocrine 2014;46:526-31. [PMID: 24272600 DOI: 10.1007/s12020-013-0089-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Xue P, Kanai M, Mori Y, Nishimura T, Uza N, Kodama Y, Kawaguchi Y, Takaori K, Matsumoto S, Uemoto S, Chiba T. Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients. Cancer Med. 2014;3:406-415. [PMID: 24519894 DOI: 10.1002/cam4.204] [Cited by in Crossref: 74] [Cited by in F6Publishing: 79] [Article Influence: 9.3] [Reference Citation Analysis]
71 Li X, Tan Q, Li H, Yang X. Predictive Value of Pretreatment Peripheral Neutrophil-to-Lymphocyte Ratio for Response to Neoadjuvant Chemotherapy and Breast Cancer Prognosis. Cancer Manag Res 2021;13:5889-98. [PMID: 34349562 DOI: 10.2147/CMAR.S313123] [Reference Citation Analysis]
72 Liu CL, Lee JJ, Liu TP, Chang YC, Hsu YC, Cheng SP. Blood neutrophil-to-lymphocyte ratio correlates with tumor size in patients with differentiated thyroid cancer. J Surg Oncol 2013;107:493-7. [PMID: 22996403 DOI: 10.1002/jso.23270] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 6.7] [Reference Citation Analysis]
73 Takakura K, Ito Z, Suka M, Kanai T, Matsumoto Y, Odahara S, Matsudaira H, Haruki K, Fujiwara Y, Saito R, Gocho T, Nakashiro K, Hamakawa H, Okamoto M, Kajihara M, Misawa T, Ohkusa T, Koido S. Comprehensive assessment of the prognosis of pancreatic cancer: peripheral blood neutrophil–lymphocyte ratio and immunohistochemical analyses of the tumour site. Scandinavian Journal of Gastroenterology 2016;51:610-7. [DOI: 10.3109/00365521.2015.1121515] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
74 Ryan CE, Gajdos C, Pourafkari L, Schwaitzberg SD, Nader ND. Can Platelet Leukocyte Ratio Improve the American College of Surgeons Surgical Risk Calculator for Patients with Surgically Resected Colorectal Cancer? J Gastrointest Surg 2021;25:2110-3. [PMID: 33532978 DOI: 10.1007/s11605-021-04938-x] [Reference Citation Analysis]
75 Abe T, Amano H, Kobayashi T, Hanada K, Nakahara M, Ohdan H, Noriyuki T. Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma. Eur J Surg Oncol 2018;44:1573-9. [PMID: 29807728 DOI: 10.1016/j.ejso.2018.04.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
76 Kwon HC, Kim SH, Oh SY, Lee S, Lee JH, Choi HJ, Park KJ, Roh MS, Kim SG, Kim HJ. Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers. 2012;17:216-222. [PMID: 22424597 DOI: 10.3109/1354750x.2012.656705] [Cited by in Crossref: 226] [Cited by in F6Publishing: 141] [Article Influence: 22.6] [Reference Citation Analysis]
77 Sierzega M, Lenart M, Rutkowska M, Surman M, Mytar B, Matyja A, Siedlar M, Kulig J. Preoperative Neutrophil-Lymphocyte and Lymphocyte-Monocyte Ratios Reflect Immune Cell Population Rearrangement in Resectable Pancreatic Cancer. Ann Surg Oncol 2017;24:808-15. [PMID: 27770341 DOI: 10.1245/s10434-016-5634-0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 7.3] [Reference Citation Analysis]
78 Ben Q, An W, Wang L, Wang W, Yu L, Yuan Y. Validation of the Pretreatment Neutrophil-Lymphocyte Ratio as a Predictor of Overall Survival in a Cohort of Patients With Pancreatic Ductal Adenocarcinoma. Pancreas 2015;44:471-7. [DOI: 10.1097/mpa.0000000000000271] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
79 Lee JM, Lee HS, Hyun JJ, Choi HS, Kim ES, Keum B, Seo YS, Jeen YT, Chun HJ, Um SH, Kim CD. Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib. World J Gastrointest Oncol 2016; 8(7): 555-562 [PMID: 27559435 DOI: 10.4251/wjgo.v8.i7.555] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
80 Badora-Rybicka A, Nowara E, Starzyczny-Słota D. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio before chemotherapy as potential prognostic factors in patients with newly diagnosed epithelial ovarian cancer. ESMO Open 2016;1:e000039. [PMID: 27843595 DOI: 10.1136/esmoopen-2016-000039] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
81 Miyamoto R, Oshiro Y, Sano N, Inagawa S, Ohkohchi N. Remnant pancreatic volume as an indicator of poor prognosis in pancreatic cancer patients after resection. Pancreatology 2019;19:716-21. [DOI: 10.1016/j.pan.2019.05.464] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
82 Na GH, Kim DG, Han JH, Kim EY, Lee SH, Hong TH, You YK. Inflammatory markers as selection criteria of hepatocellular carcinoma in living-donor liver transplantation. World J Gastroenterol 2014; 20(21): 6594-6601 [PMID: 24914382 DOI: 10.3748/wjg.v20.i21.6594] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
83 Kim YH, Choi WJ. The effectiveness of postoperative neutrophils to lymphocytes ratio in predicting long-term recurrence after stomach cancer surgery. J Korean Surg Soc 2012;83:352-9. [PMID: 23230553 DOI: 10.4174/jkss.2012.83.6.352] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
84 Liu H, Wu Y, Wang Z, Yao Y, Chen F, Zhang H, Wang Y, Song Y. Pretreatment platelet-to-lymphocyte ratio (PLR) as a predictor of response to first-line platinum-based chemotherapy and prognosis for patients with non-small cell lung cancer. J Thorac Dis 2013;5:783-9. [PMID: 24409356 DOI: 10.3978/j.issn.2072-1439.2013.12.34] [Cited by in F6Publishing: 37] [Reference Citation Analysis]
85 Sharma R, Katiyar V, Gurjar H, Sharma M, Goda R, Vora Z. Is medulloblastoma associated with systemic immunomodulation? - A comparative analysis of preoperative inflammatory markers. Surg Neurol Int 2020;11:86. [PMID: 32494368 DOI: 10.25259/SNI_336_2019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
86 Kurtul BE, Ozer PA. Neutrophil-to-lymphocyte ratio in ocular diseases: a systematic review. Int J Ophthalmol 2019;12:1951-8. [PMID: 31850181 DOI: 10.18240/ijo.2019.12.18] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
87 Grimes N, Hannan C, Tyson M, Thwaini A. The role of neutrophil-lymphocyte ratio as a prognostic indicator in patients undergoing nephrectomy for renal cell carcinoma. Can Urol Assoc J 2018;12:E345-8. [PMID: 29603920 DOI: 10.5489/cuaj.4872] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
88 Takeda T, Yamada T, Tanimura K, Nakano T, Ishida M, Tachibana Y, Shiotsu S, Horiuchi S, Hibino M, Okada A, Chihara Y, Takayama K. Prognostic Markers of Survival among Japanese Patients with Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer Receiving First-Line Alectinib. Diagnostics (Basel) 2021;11:2170. [PMID: 34943412 DOI: 10.3390/diagnostics11122170] [Reference Citation Analysis]
89 Neofytou K, Smyth EC, Giakoustidis A, Khan AZ, Cunningham D, Mudan S. Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factor. Med Oncol 2014;31:239. [PMID: 25218270 DOI: 10.1007/s12032-014-0239-6] [Cited by in Crossref: 56] [Cited by in F6Publishing: 62] [Article Influence: 7.0] [Reference Citation Analysis]
90 Xiao Y, Xie Z, Shao Z, Chen W, Xie H, Qin G, Zhao N. Prognostic value of postdiagnostic inflammation-based scores in short-term overall survival of advanced pancreatic ductal adenocarcinoma patients. Medicine (Baltimore) 2017;96:e9247. [PMID: 29390358 DOI: 10.1097/MD.0000000000009247] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
91 Baranyai Z, Krzystanek M, Jósa V, Dede K, Agoston E, Szász AM, Sinkó D, Szarvas V, Salamon F, Eklund AC, Szállási Z, Jakab F. The comparison of thrombocytosis and platelet-lymphocyte ratio as potential prognostic markers in colorectal cancer. Thromb Haemost 2014;111:483-90. [PMID: 24285160 DOI: 10.1160/TH13-08-0632] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
92 Cıcek E, Demırel B, Cıcek IE, Kıraç AS, Eren I. Increased Neutrophil-lymphocyte and Platelet-lymphocyte Ratios in Male Heroin Addicts: A Prospective Controlled Study. Clin Psychopharmacol Neurosci 2018;16:190-6. [PMID: 29739133 DOI: 10.9758/cpn.2018.16.2.190] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
93 Yang C, Cheng H, Zhang Y, Fan K, Luo G, Fan Z, Huang Q, Lu Y, Jin K, Wang Z, Yu X, Liu C. Anergic natural killer cells educated by tumor cells are associated with a poor prognosis in patients with advanced pancreatic ductal adenocarcinoma. Cancer Immunol Immunother. 2018;67:1815-1823. [PMID: 30167864 DOI: 10.1007/s00262-018-2235-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
94 Acet H, Ertaş F, Bilik MZ, Akıl MA, Özyurtlu F, Aydın M, Oylumlu M, Polat N, Yüksel M, Yıldız A, Kaya H, Akyüz A, Ayçiçek H, Özbek M, Toprak N. The relationship between neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and thrombolysis in myocardial infarction risk score in patients with ST elevation acute myocardial infarction before primary coronary intervention. Postepy Kardiol Interwencyjnej 2015;11:126-35. [PMID: 26161105 DOI: 10.5114/pwki.2015.52286] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
95 Dolan RD, Lim J, McSorley ST, Horgan PG, McMillan DC. The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis. Sci Rep. 2017;7:16717. [PMID: 29196718 DOI: 10.1038/s41598-017-16955-5] [Cited by in Crossref: 112] [Cited by in F6Publishing: 111] [Article Influence: 22.4] [Reference Citation Analysis]
96 Mengxue Z, Ling G, Lili W, Ying L. Effect of scar-producing moxibustion at the acupoints Zusanli (ST 36) and Feishu (BL 13) on neutrophil-to-lymphocyte ratio and quality of life in patients with non-small-cell lung cancer: A randomized, controlled trial. Journal of Traditional Chinese Medicine 2018;38:439-46. [DOI: 10.1016/s0254-6272(18)30636-8] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
97 Belen E, Özal E, Püsüroğlu H. Relationship between the presence of left atrial thrombus in patients with mitral stenosis and platelet-to-lymphocyte ratio. Anatol J Cardiol 2016;16:673-7. [PMID: 27488748 DOI: 10.5152/AnatolJCardiol.2015.6485] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
98 Pointer DT Jr, Roife D, Powers BD, Murimwa G, Elessawy S, Thompson ZJ, Schell MJ, Hodul PJ, Pimiento JM, Fleming JB, Malafa MP. Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma. BMC Cancer 2020;20:750. [PMID: 32782024 DOI: 10.1186/s12885-020-07182-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
99 Kos M, Hocazade C, Kos FT, Uncu D, Karakas E, Dogan M, Uncu HG, Yildirim N, Zengin N. Prognostic role of pretreatment platelet/lymphocyte ratio in patients with non-small cell lung cancer. Wien Klin Wochenschr 2016;128:635-40. [PMID: 25720573 DOI: 10.1007/s00508-015-0724-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
100 Negoi I, Beuran M, Hostiuc S, El-Hussuna A, de-Madaria E. Platelet-to-lymphocyte ratio and CA19-9 are simple and informative prognostic factors in patients with resected pancreatic cancer. Hepatobiliary Pancreat Dis Int 2019;18:203-5. [PMID: 31000337 DOI: 10.1016/j.hbpd.2019.03.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
101 Xue A, Gao X, Fang Y, Shu P, Ling J, Shen K, Sun Y, Qin J, Qin X, Hou Y. Incorporation of NLR into NIH stratification system increases predictive accuracy for surgically resected gastrointestinal stromal tumors. Acta Biochim Biophys Sin (Shanghai) 2017;49:179-85. [PMID: 28039147 DOI: 10.1093/abbs/gmw123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
102 Gu X, Gao XS, Cui M, Xie M, Peng C, Bai Y, Guo W, Han L, Gu X, Xiong W. Clinicopathological and prognostic significance of platelet to lymphocyte ratio in patients with gastric cancer. Oncotarget. 2016;7:49878-49887. [PMID: 27409665 DOI: 10.18632/oncotarget.10490] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 9.3] [Reference Citation Analysis]
103 Utsumi M, Aoki H, Nagahisa S, Nishimura S, Une Y, Kimura Y, Taniguchi F, Arata T, Katsuda K, Tanakaya K. Preoperative Nutritional Assessment Using the Controlling Nutritional Status Score to Predict Pancreatic Fistula After Pancreaticoduodenectomy. In Vivo 2020;34:1931-9. [PMID: 32606165 DOI: 10.21873/invivo.11990] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
104 Haksoyler V, Topkan E. Prognostic Utility of Prechemoradiotherapy Albumin-to-Alkaline Phosphatase Ratio in Unresectable Locally Advanced Pancreatic Carcinoma Patients. Gastroenterol Res Pract 2021;2021:6647145. [PMID: 33927759 DOI: 10.1155/2021/6647145] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Kim JY, Park T, Jeong SH, Jeong CY, Ju YT, Lee YJ, Hong SC, Ha WS, Choi SK, Jung EJ. Prognostic importance of baseline neutrophil to lymphocyte ratio in patients with advanced papillary thyroid carcinomas. Endocrine 2014;46:526-31. [PMID: 24272600 DOI: 10.1007/s12020-013-0089-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 4.0] [Reference Citation Analysis]
106 Racz JM, Cleghorn MC, Jimenez MC, Atenafu EG, Jackson TD, Okrainec A, Venkat Raghavan L, Quereshy FA. Predictive Ability of Blood Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Gastrointestinal Stromal Tumors. Ann Surg Oncol 2015;22:2343-50. [DOI: 10.1245/s10434-014-4265-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
107 Bugada D, Allegri M, Lavand'homme P, De Kock M, Fanelli G. Inflammation-based scores: a new method for patient-targeted strategies and improved perioperative outcome in cancer patients. Biomed Res Int 2014;2014:142425. [PMID: 24877056 DOI: 10.1155/2014/142425] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
108 Nakamura K, Nakayama K, Tatsumi N, Minamoto T, Ishibashi T, Ohnishi K, Yamashita H, Ono R, Sasamori H, Razia S, Kamrunnahar S, Ishikawa M, Kyo S. Prognostic significance of pre-treatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in non-surgically treated uterine cervical carcinoma. Mol Clin Oncol 2018;9:138-44. [PMID: 30101010 DOI: 10.3892/mco.2018.1646] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
109 Li W, Tao L, Lu M, Xiu D. Prognostic role of platelet to lymphocyte ratio in pancreatic cancers: A meta-analysis including 3028 patients. Medicine (Baltimore) 2018;97:e9616. [PMID: 29465553 DOI: 10.1097/MD.0000000000009616] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
110 Mattavelli D, Lombardi D, Missale F, Calza S, Battocchio S, Paderno A, Bozzola A, Bossi P, Vermi W, Piazza C, Nicolai P. Prognostic Nomograms in Oral Squamous Cell Carcinoma: The Negative Impact of Low Neutrophil to Lymphocyte Ratio. Front Oncol 2019;9:339. [PMID: 31114760 DOI: 10.3389/fonc.2019.00339] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
111 Rebonato A, Graziosi L, Maiettini D, Marino E, De Angelis V, Brunese L, Mosca S, Metro G, Rossi M, Orgera G, Scialpi M, Donini A. Inflammatory Markers as Prognostic Factors of Survival in Patients Affected by Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Gastroenterol Res Pract 2017;2017:4164130. [PMID: 28894464 DOI: 10.1155/2017/4164130] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
112 Xu ZS, Zhang FP, Zhang Y, Ou-Yang YP, Yu XW, Wang WL, Xu WJ, Luo ZQ. Prognostic role of the pre-treatment platelet-lymphocyte ratio in pancreatic cancer: a meta-analysis. Oncotarget 2017;8:99003-12. [PMID: 29228745 DOI: 10.18632/oncotarget.20871] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
113 Cannon NA, Meyer J, Iyengar P, Ahn C, Westover KD, Choy H, Timmerman R. Neutrophil–Lymphocyte and Platelet–Lymphocyte Ratios as Prognostic Factors after Stereotactic Radiation Therapy for Early-Stage Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology 2015;10:280-5. [DOI: 10.1097/jto.0000000000000399] [Cited by in Crossref: 88] [Cited by in F6Publishing: 70] [Article Influence: 12.6] [Reference Citation Analysis]
114 Fu X, Zhang Y, Yang J, Qi Y, Ming Y, Sun M, Shang Y, Yang Y, Zhu X, Gao Q. Efficacy and safety of trastuzumab as maintenance or palliative therapy in advanced HER2-positive gastric cancer. Onco Targets Ther 2018;11:6091-100. [PMID: 30275713 DOI: 10.2147/OTT.S174138] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
115 Marques P, de Vries F, Dekkers OM, van Furth WR, Korbonits M, Biermasz NR, Pereira AM. Pre-operative serum inflammation-based scores in patients with pituitary adenomas. Pituitary 2021;24:334-50. [PMID: 33230695 DOI: 10.1007/s11102-020-01112-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
116 Dogan M, Eren T, Ozdemir N, Cigirgan CL, Zengin N. The relationship between platelet-lymphocyte ratio, neutrophil-lymphocyte ratio, and survival in metastatic gastric cancer on firstline modified docetaxel and cisplatinum plus 5 Fluorourasil Regimen: A single institute experience. Saudi J Gastroenterol. 2015;21:320-324. [PMID: 26458860 DOI: 10.4103/1319-3767.166207] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
117 Çiçek G, Açıkgoz SK, Bozbay M, Altay S, Uğur M, Uluganyan M, Uyarel H. Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio Combination Can Predict Prognosis in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Angiology 2015;66:441-7. [DOI: 10.1177/0003319714535970] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
118 Zhou X, Du Y, Huang Z, Xu J, Qiu T, Wang J, Wang T, Zhu W, Liu P. Prognostic value of PLR in various cancers: a meta-analysis. PLoS One. 2014;9:e101119. [PMID: 24968121 DOI: 10.1371/journal.pone.0101119] [Cited by in Crossref: 135] [Cited by in F6Publishing: 160] [Article Influence: 16.9] [Reference Citation Analysis]
119 Liou GY. Inflammatory Cytokine Signaling during Development of Pancreatic and Prostate Cancers. J Immunol Res. 2017;2017:7979637. [PMID: 29379802 DOI: 10.1155/2017/7979637] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
120 Jabłońska B, Pawlicki K, Mrowiec S. Associations between Nutritional and Immune Status and Clinicopathologic Factors in Patients with Pancreatic Cancer: A Comprehensive Analysis. Cancers (Basel) 2021;13:5041. [PMID: 34680194 DOI: 10.3390/cancers13205041] [Reference Citation Analysis]
121 Paramanathan A, Saxena A, Morris DL. A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours. Surgical Oncology 2014;23:31-9. [DOI: 10.1016/j.suronc.2013.12.001] [Cited by in Crossref: 176] [Cited by in F6Publishing: 183] [Article Influence: 22.0] [Reference Citation Analysis]
122 Cescon M, Bertuzzo VR, Ercolani G, Ravaioli M, Odaldi F, Pinna AD. Liver transplantation for hepatocellular carcinoma: Role of inflammatory and immunological state on recurrence and prognosis. World J Gastroenterol 2013; 19(48): 9174-9182 [PMID: 24409045 DOI: 10.3748/wjg.v19.i48.9174] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 42] [Article Influence: 4.0] [Reference Citation Analysis]
123 Feng JF, Huang Y, Zhao Q, Chen QX. Clinical significance of preoperative neutrophil lymphocyte ratio versus platelet lymphocyte ratio in patients with small cell carcinoma of the esophagus. ScientificWorldJournal 2013;2013:504365. [PMID: 24089602 DOI: 10.1155/2013/504365] [Cited by in Crossref: 23] [Cited by in F6Publishing: 37] [Article Influence: 2.6] [Reference Citation Analysis]
124 Yuksel OH, Verit A, Sahin A, Urkmez A, Uruc F. White blood cell counts and neutrophil to lymphocyte ratio in the diagnosis of testicular cancer: a simple secondary serum tumor marker. Int Braz J Urol 2016;42:53-9. [PMID: 27136467 DOI: 10.1590/S1677-5538.IBJU.2014.0593] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
125 Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88:218-230. [PMID: 23602134 DOI: 10.1016/j.critrevonc.2013.03.010] [Cited by in Crossref: 645] [Cited by in F6Publishing: 661] [Article Influence: 71.7] [Reference Citation Analysis]
126 Li SH, Wang QX, Yang ZY, Jiang W, Li C, Sun P, Wei W, Shi M, Guo RP. Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis. World J Gastroenterol 2017; 23(17): 3122-3132 [PMID: 28533669 DOI: 10.3748/wjg.v23.i17.3122] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
127 Sugiura T, Uesaka K, Kanemoto H, Mizuno T, Okamura Y. Elevated preoperative neutrophil-to-lymphocyte ratio as a predictor of survival after gastroenterostomy in patients with advanced pancreatic adenocarcinoma. Ann Surg Oncol. 2013;20:4330-4337. [PMID: 23982254 DOI: 10.1245/s10434-013-3227-8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
128 Ji WH, Jiang YH, Ji YL, Li B, Mao WM. Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy. Dis Esophagus 2016;29:403-11. [PMID: 25625421 DOI: 10.1111/dote.12322] [Cited by in Crossref: 10] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
129 Zhang H, Xia H, Zhang L, Zhang B, Yue D, Wang C. Clinical significance of preoperative neutrophil–lymphocyte vs platelet–lymphocyte ratio in primary operable patients with non–small cell lung cancer. The American Journal of Surgery 2015;210:526-35. [DOI: 10.1016/j.amjsurg.2015.03.022] [Cited by in Crossref: 44] [Cited by in F6Publishing: 50] [Article Influence: 6.3] [Reference Citation Analysis]
130 Chen S, Na N, Jian Z. Pretreatment platelet count as a prognostic factor in patients with pancreatic cancer: a systematic review and meta-analysis. Onco Targets Ther 2018;11:59-65. [PMID: 29317834 DOI: 10.2147/OTT.S147715] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
131 Hsu CC, Liu KH, Chang PH, Chen PT, Hung CY, Hsueh SW, Yeh KY, Chen YY, Lu CH, Hung YS, Chou WC. Development and validation of a prognostic nomogram to predict survival in patients with advanced pancreatic cancer receiving second-line palliative chemotherapy. J Gastroenterol Hepatol 2020;35:1694-703. [PMID: 31711261 DOI: 10.1111/jgh.14926] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
132 Alagappan M, Pollom EL, von Eyben R, Kozak MM, Aggarwal S, Poultsides GA, Koong AC, Chang DT. Albumin and Neutrophil-Lymphocyte Ratio (NLR) Predict Survival in Patients With Pancreatic Adenocarcinoma Treated With SBRT. Am J Clin Oncol. 2018;41:242-247. [PMID: 26757436 DOI: 10.1097/coc.0000000000000263] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
133 Mowbray NG, Griffith D, Hammoda M, Shingler G, Kambal A, Al-Sarireh B. A meta-analysis of the utility of the neutrophil-to-lymphocyte ratio in predicting survival after pancreatic cancer resection. HPB (Oxford) 2018;20:379-84. [PMID: 29336893 DOI: 10.1016/j.hpb.2017.12.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
134 Martin HL, Ohara K, Kiberu A, Van Hagen T, Davidson A, Khattak MA. Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer. Intern Med J. 2014;44:676-682. [PMID: 24750233 DOI: 10.1111/imj.12453] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 10.3] [Reference Citation Analysis]
135 Teo M, Sharial MSNM, Mcdonnell F, Conlon KC, Ridgway PF, Mcdermott RS. Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Advanced Pancreatic Ductal Adenocarcinoma: Impact of Baseline Fluctuation and Changes during Chemotherapy. Tumori 2013;99:516-22. [DOI: 10.1177/030089161309900413] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
136 Oylumlu M, Yıldız A, Oylumlu M, Yüksel M, Polat N, Bilik MZ, Akyüz A, Aydın M, Acet H, Soydinç S. Platelet-to-lymphocyte ratio is a predictor of in-hospital mortality patients with acute coronary syndrome. Anatol J Cardiol 2015;15:277-83. [PMID: 25413224 DOI: 10.5152/akd.2014.5366] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
137 Fan W, Zhang Y, Wang Y, Yao X, Yang J, Li J. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolization. PLoS One. 2015;10:e0119312. [PMID: 25742141 DOI: 10.1371/journal.pone.0119312] [Cited by in Crossref: 35] [Cited by in F6Publishing: 45] [Article Influence: 5.0] [Reference Citation Analysis]
138 Nakagawa K, Sho M, Akahori T, Nagai M, Nakamura K, Takagi T, Tanaka T, Nishiofuku H, Ohbayashi C, Kichikawa K, Ikeda N. Significance of the inflammation-based prognostic score in recurrent pancreatic cancer. Pancreatology. 2019;19:722-728. [PMID: 31153778 DOI: 10.1016/j.pan.2019.05.461] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
139 Piciucchi M, Stigliano S, Archibugi L, Zerboni G, Signoretti M, Barucca V, Valente R, Fave GD, Capurso G. The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer Patients. Int J Mol Sci. 2017;18. [PMID: 28353661 DOI: 10.3390/ijms18040730] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
140 Cunha LL, Marcello MA, Ward LS. The role of the inflammatory microenvironment in thyroid carcinogenesis. Endocr Relat Cancer 2014;21:R85-R103. [PMID: 24302667 DOI: 10.1530/ERC-13-0431] [Cited by in Crossref: 58] [Cited by in F6Publishing: 36] [Article Influence: 7.3] [Reference Citation Analysis]
141 Zhou X, Xu L, Huang Z, Zhang L, Zhang H, Zhu W, Liu P. The hematologic markers as prognostic factors in patients with resectable gastric cancer. Cancer Biomark 2016;17:359-67. [PMID: 27434296 DOI: 10.3233/CBM-160648] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
142 Turpin A, El Amrani M, Bachet JB, Pietrasz D, Schwarz L, Hammel P. Adjuvant Pancreatic Cancer Management: Towards New Perspectives in 2021. Cancers (Basel) 2020;12:E3866. [PMID: 33371464 DOI: 10.3390/cancers12123866] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
143 Kim SM, Kim EH, Kim BH, Kim JH, Park SB, Nam YJ, Ahn KH, Oh MY, Kim WJ, Jeon YK, Kim SS, Kim YK, Kim IJ. Association of the Preoperative Neutrophil-to-ymphocyte Count Ratio and Platelet-to-Lymphocyte Count Ratio with Clinicopathological Characteristics in Patients with Papillary Thyroid Cancer. Endocrinol Metab (Seoul) 2015;30:494-501. [PMID: 26354491 DOI: 10.3803/EnM.2015.30.4.494] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
144 d'Engremont C, Vernerey D, Pointet AL, Simone G, Fein F, Heyd B, Koch S, Vuitton L, Kim S, Jary M, Lamfichek N, Turco C, Lakkis Z, Berger A, Bonnetain F, Taieb J, Bachellier P, Borg C. Additive value of pre-operative and one-month post-operative lymphocyte count for death-risk stratification in patients with resectable pancreatic cancer: a multicentric study. BMC Cancer 2016;16:823. [PMID: 27782813 DOI: 10.1186/s12885-016-2860-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
145 Marques P, de Vries F, Dekkers OM, Korbonits M, Biermasz NR, Pereira AM. Serum inflammation-based scores in endocrine tumors. J Clin Endocrinol Metab 2021:dgab238. [PMID: 33837783 DOI: 10.1210/clinem/dgab238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Kubota K. Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer. Br J Cancer 2013;109:401-7. [PMID: 23820256 DOI: 10.1038/bjc.2013.350] [Cited by in Crossref: 102] [Cited by in F6Publishing: 108] [Article Influence: 11.3] [Reference Citation Analysis]
147 McLellan P, Henriques J, Ksontini F, Doat S, Hammel P, Desrame J, Trouilloud I, Louvet C, Pietrasz D, Vernerey D, Bachet JB. Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinoma. Clin Res Hepatol Gastroenterol 2021;45:101541. [PMID: 33055007 DOI: 10.1016/j.clinre.2020.08.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
148 Turri-zanoni M, Salzano G, Lambertoni A, Giovannardi M, Karligkiotis A, Battaglia P, Castelnuovo P. Prognostic value of pretreatment peripheral blood markers in paranasal sinus cancer: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio: Hematologic markers as prognostic factors in sinonasal cancers. Head Neck 2017;39:730-6. [DOI: 10.1002/hed.24681] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
149 Yasar HA, Bir Yucel K, Arslan C, Ucar G, Karakaya S, Bilgin B, Taban H, Kucukarda A, Erturk I, Hızal M, Yıldız B, Yıldırım N, Demirci U, Sendur MA, Utkan G, Kılıckap S, Cicin I, Karadurmus N, Ürün Y. The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer. J Oncol Pharm Pract 2020;26:1110-6. [DOI: 10.1177/1078155219883004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
150 Aires FT, Dedivitis RA, Kulcsar MAV, Ramos DM, Cernea CR. Neutrophil-to-lymphocyte ratio as a prognostic factor for pharyngocutaneous fistula after total laryngectomy. Acta Otorhinolaryngol Ital 2018;38:31-7. [PMID: 29756613 DOI: 10.14639/0392-100X-1572] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
151 Chen L, Lou Y, Chen Y, Yang J. Prognostic value of the neutrophil-to-lymphocyte ratio in patients with acute-on-chronic liver failure. Int J Clin Pract 2014;68:1034-40. [PMID: 24666824 DOI: 10.1111/ijcp.12408] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
152 Acet H, Ertaş F, Akıl MA, Özyurtlu F, Polat N, Bilik MZ, Aydın M, Oylumlu M, Yüksel M, Yıldız A, Kaya H, Akyüz A, Özbek M. Relationship Between Hematologic Indices and Global Registry of Acute Coronary Events Risk Score in Patients With ST-Segment Elevation Myocardial Infarction. Clin Appl Thromb Hemost 2016;22:60-8. [PMID: 24816530 DOI: 10.1177/1076029614533145] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
153 Sugiura T, Okamura Y, Ito T, Yamamoto Y, Ashida R, Yoshida Y, Tanaka M, Uesaka K. Prognostic Scoring System for Patients Who Present with a Gastric Outlet Obstruction Caused by Advanced Pancreatic Adenocarcinoma. World J Surg 2017;41:2619-24. [PMID: 28439647 DOI: 10.1007/s00268-017-4027-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
154 Shirai Y, Shiba H, Sakamoto T, Horiuchi T, Haruki K, Fujiwara Y, Futagawa Y, Ohashi T, Yanaga K. Preoperative platelet to lymphocyte ratio predicts outcome of patients with pancreatic ductal adenocarcinoma after pancreatic resection. Surgery. 2015;158:360-365. [PMID: 26032829 DOI: 10.1016/j.surg.2015.03.043] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 6.3] [Reference Citation Analysis]
155 Rossi S, Basso M, Strippoli A, Schinzari G, D'Argento E, Larocca M, Cassano A, Barone C. Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? Clin Colorectal Cancer 2017;16:264-74. [PMID: 28412137 DOI: 10.1016/j.clcc.2017.03.015] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
156 Xue A, Chang JW, Chung L, Samra J, Hugh T, Gill A, Butturini G, Baxter RC, Smith RC. Serum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinoma. Br J Cancer. 2012;107:1883-1891. [PMID: 23169340 DOI: 10.1038/bjc.2012.458] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
157 Okumura S, Kaido T, Hamaguchi Y, Fujimoto Y, Masui T, Mizumoto M, Hammad A, Mori A, Takaori K, Uemoto S. Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. Surgery. 2015;157:1088-1098. [PMID: 25799468 DOI: 10.1016/j.surg.2015.02.002] [Cited by in Crossref: 123] [Cited by in F6Publishing: 116] [Article Influence: 17.6] [Reference Citation Analysis]
158 Ng SP, Bahig H, Wang J, Cardenas CE, Lucci A, Hall CS, Meas S, Sarli VN, Yuan Y, Urbauer DL, Ding Y, Ikner S, Dinh V, Elgohari BA, Johnson JM, Skinner HD, Gunn GB, Garden AS, Phan J, Rosenthal DI, Morrison WH, Frank SJ, Hutcheson KA, Mohamed ASR, Lai SY, Ferrarotto R, MacManus MP, Fuller CD. Predicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matching 'liquid biopsy' and quantitative tumor modeling. BMC Cancer 2018;18:903. [PMID: 30231854 DOI: 10.1186/s12885-018-4808-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
159 Cheong TY, Hong SD, Jung KW, So YK. The diagnostic predictive value of neutrophil-to-lymphocyte ratio in thyroid cancer adjusted for tumor size. PLoS One 2021;16:e0251446. [PMID: 33974674 DOI: 10.1371/journal.pone.0251446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
160 Tek M, Çetin MS, Diker E, Çelebi S, Amasyali B, Berkalp B. Platelet to lymphocyte ratio predicts all-cause mortality in patients with carotid arterial disease. Rom J Intern Med 2019;57:159-65. [PMID: 30521474 DOI: 10.2478/rjim-2018-0040] [Reference Citation Analysis]
161 Chen Y, Chen K, Xiao X, Nie Y, Qu S, Gong C, Su F, Song E. Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study. BMC Cancer. 2016;16:320. [PMID: 27198767 DOI: 10.1186/s12885-016-2352-8] [Cited by in Crossref: 62] [Cited by in F6Publishing: 74] [Article Influence: 10.3] [Reference Citation Analysis]
162 Cho Y, Kim JW, Yoon HI, Lee CG, Keum KC, Lee IJ. The Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Head and Neck Cancer Patients Treated with Radiotherapy. J Clin Med 2018;7:E512. [PMID: 30513928 DOI: 10.3390/jcm7120512] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
163 Asaoka T, Miyamoto A, Maeda S, Tsujie M, Hama N, Yamamoto K, Miyake M, Haraguchi N, Nishikawa K, Hirao M, Ikeda M, Sekimoto M, Nakamori S. Prognostic impact of preoperative NLR and CA19-9 in pancreatic cancer. Pancreatology. 2016;16:434-440. [PMID: 26852169 DOI: 10.1016/j.pan.2015.10.006] [Cited by in Crossref: 49] [Cited by in F6Publishing: 57] [Article Influence: 7.0] [Reference Citation Analysis]
164 Morimoto M, Honjo S, Sakamoto T, Yagyu T, Uchinaka E, Hanaki T, Watanabe J, Matsunaga T, Yamamoto M, Fukumoto Y, Tokuyasu N, Fujiwara Y. Prognostic Impact of Pre- and Post-operative P-CRP Levels in Pancreatic Cancer Patients. Yonago Acta Med 2020;63:70-8. [PMID: 32158336 DOI: 10.33160/yam.2020.02.011] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
165 Gao F, Li X, Geng M, Ye X, Liu H, Liu Y, Wan G, Wang X. Pretreatment neutrophil-lymphocyte ratio: an independent predictor of survival in patients with hepatocellular carcinoma. Medicine (Baltimore). 2015;94:e639. [PMID: 25789957 DOI: 10.1097/md.0000000000000639] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
166 Kozak MM, von Eyben R, Pai JS, Anderson EM, Welton ML, Shelton AA, Kin C, Koong AC, Chang DT. The Prognostic Significance of Pretreatment Hematologic Parameters in Patients Undergoing Resection for Colorectal Cancer. Am J Clin Oncol. 2015; Epub ahead of print. [PMID: 25756348 DOI: 10.1097/coc.0000000000000183] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
167 Kaneko M, Nozawa H, Sasaki K, Hongo K, Hiyoshi M, Tada N, Murono K, Nirei T, Kawai K, Sunami E, Tsuno NH, Kitayama J. Elevated neutrophil to lymphocyte ratio predicts poor prognosis in advanced colorectal cancer patients receiving oxaliplatin-based chemotherapy. Oncology 2012;82:261-8. [PMID: 22538399 DOI: 10.1159/000337228] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
168 Mizunuma M, Yokoyama Y, Futagami M, Aoki M, Takai Y, Mizunuma H. The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer. Int J Clin Oncol 2015;20:989-96. [PMID: 25736530 DOI: 10.1007/s10147-015-0807-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 4.9] [Reference Citation Analysis]
169 Taşoğlu İ, Sert D, Colak N, Uzun A, Songur M, Ecevit A. Neutrophil-lymphocyte ratio and the platelet-lymphocyte ratio predict the limb survival in critical limb ischemia. Clin Appl Thromb Hemost 2014;20:645-50. [PMID: 23393289 DOI: 10.1177/1076029613475474] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
170 Beltran BE, Aguilar C, Quiñones P, Morales D, Chavez JC, Sotomayor EM, Castillo JJ. The neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with peripheral T-cell lymphoma, unspecified. Leuk Lymphoma 2016;57:58-62. [PMID: 25926063 DOI: 10.3109/10428194.2015.1045897] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
171 Gong W, Yang S, Yang X, Guo F. Blood preoperative neutrophil-to-lymphocyte ratio is correlated with TNM stage in patients with papillary thyroid cancer. Clinics (Sao Paulo) 2016;71:311-4. [PMID: 27438563 DOI: 10.6061/clinics/2016(06)04] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
172 Mohindroo C, Hasanov M, Rogers JE, Dong W, Prakash LR, Baydogan S, Mizrahi JD, Overman MJ, Varadhachary GR, Wolff RA, Javle MM, Fogelman DR, Lotze MT, Kim MP, Katz MHG, Pant S, Tzeng CD, McAllister F. Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients. Cancer Med 2021;10:5041-50. [PMID: 34250759 DOI: 10.1002/cam4.3870] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
173 Cain DJ, Del Arroyo AG, Ackland GL. Man is the new mouse: Elective surgery as a key translational model for multi-organ dysfunction and sepsis. J Intensive Care Soc 2015;16:154-63. [PMID: 28979398 DOI: 10.1177/1751143714564826] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
174 Evans A, Costello E. The role of inflammatory cells in fostering pancreatic cancer cell growth and invasion. Front Physiol. 2012;3:270. [PMID: 22969725 DOI: 10.3389/fphys.2012.00270] [Cited by in Crossref: 11] [Cited by in F6Publishing: 40] [Article Influence: 1.1] [Reference Citation Analysis]
175 Zheng YZ, Dai SQ, Li W, Cao X, Li Y, Zhang LJ, Fu JH, Wang JY. Prognostic value of preoperative mean corpuscular volume in esophageal squamous cell carcinoma. World J Gastroenterol 2013; 19(18): 2811-2817 [PMID: 23687419 DOI: 10.3748/wjg.v19.i18.2811] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
176 Okyay GU, İnal S, Öneç K, Er RE, Paşaoğlu Ö, Paşaoğlu H, Derici Ü, Erten Y. Neutrophil to Lymphocyte Ratio in Evaluation of Inflammation in Patients with Chronic Kidney Disease. Renal Failure 2012;35:29-36. [DOI: 10.3109/0886022x.2012.734429] [Cited by in Crossref: 73] [Cited by in F6Publishing: 41] [Article Influence: 7.3] [Reference Citation Analysis]
177 He YF, Luo HQ, Wang W, Chen J, Yao YW, Yan Y, Wu SS, Hu XX, Ke LH, Niu JY, Li HM, Ji CS, Hu B. Preoperative NLR and PLR in the middle or lower ESCC patients with radical operation. Eur J Cancer Care (Engl) 2017;26. [PMID: 26947428 DOI: 10.1111/ecc.12445] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
178 Chen ZN, Huang YR, Chen X, Liu K, Li SJ, Yang H, Chen W, Ren BQ, Luo ZH. Value of neutrophil-to-lymphocyte ratio as a marker of renal damage in patients with H-type hypertension. Biomark Med 2021;15:637-46. [PMID: 34039027 DOI: 10.2217/bmm-2020-0638] [Reference Citation Analysis]
179 Zhang H, Zhang L, Zhu K, Shi B, Yin Y, Zhu J, Yue D, Zhang B, Wang C. Prognostic Significance of Combination of Preoperative Platelet Count and Neutrophil-Lymphocyte Ratio (COP-NLR) in Patients with Non-Small Cell Lung Cancer: Based on a Large Cohort Study. PLoS One 2015;10:e0126496. [PMID: 25950176 DOI: 10.1371/journal.pone.0126496] [Cited by in Crossref: 45] [Cited by in F6Publishing: 58] [Article Influence: 6.4] [Reference Citation Analysis]
180 Rejec A, Butinar J, Gawor J, Petelin M. Evaluation of Complete Blood Count Indices (NLR, PLR, MPV/PLT, and PLCRi) in Healthy Dogs, Dogs With Periodontitis, and Dogs With Oropharyngeal Tumors as Potential Biomarkers of Systemic Inflammatory Response. J Vet Dent 2017;34:231-40. [PMID: 28936913 DOI: 10.1177/0898756417731775] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
181 Erdogan Yucel E, Demiral Sezer S. Relationship Between the Neutrophil to Lymphocyte Ratio and the Presence and Size of Thyroid Nodules. Cureus 2019;11:e3866. [PMID: 30899617 DOI: 10.7759/cureus.3866] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
182 Yoldas H, Karagoz I, Ogun MN, Velioglu Y, Yildiz I, Bilgi M, Demirhan A. Novel Mortality Markers for Critically Ill Patients. J Intensive Care Med 2020;35:383-5. [PMID: 29334832 DOI: 10.1177/0885066617753389] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
183 Ida M, Tachiiri Y, Sato M, Kawaguchi M. Neutrophil‐to‐lymphocyte ratio as indicator to severe complication after pancreaticoduodenectomy or distal pancreatectomy. Acta Anaesthesiol Scand 2019;63:739-44. [DOI: 10.1111/aas.13341] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
184 Luo X, Yu B, Jiang N, Du Q, Ye X, Li H, Wang WQ, Zhai Q. Chemotherapy-Induced Reduction of Neutrophil-to-Lymphocyte Ratio Is Associated With Better Survival in Pancreatic Adenocarcinoma: A Meta-Analysis. Cancer Control 2020;27:1073274820977135. [PMID: 33269614 DOI: 10.1177/1073274820977135] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
185 Asari S, Matsumoto I, Toyama H, Shinzeki M, Goto T, Ishida J, Ajiki T, Fukumoto T, Ku Y. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios. Surg Today 2016;46:583-92. [DOI: 10.1007/s00595-015-1206-3] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
186 Nayak A, McDowell DT, Kellie SJ, Karpelowsky J. Elevated Preoperative Neutrophil-Lymphocyte Ratio is Predictive of a Poorer Prognosis for Pediatric Patients with Solid Tumors. Ann Surg Oncol 2017;24:3456-62. [PMID: 28718035 DOI: 10.1245/s10434-017-6006-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
187 Yılmaz B, Şengül E, Gül A, Alabalık U, Özkurt FE, Akdağ M, Topçu İ. Neutrophil-Lymphocyte Ratio as a Prognostic Factor in Laryngeal Carcinoma. Indian J Otolaryngol Head Neck Surg 2018;70:175-9. [PMID: 29977836 DOI: 10.1007/s12070-014-0769-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
188 Silvestris N, Longo V, Cellini F, Reni M, Bittoni A, Cataldo I, Partelli S, Falconi M, Scarpa A, Brunetti O, Lorusso V, Santini D, Morganti A, Valentini V, Cascinu S. Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma. Crit Rev Oncol Hematol 2016;98:309-24. [PMID: 26653573 DOI: 10.1016/j.critrevonc.2015.11.016] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
189 Ferrari SM, Fallahi P, Galdiero MR, Ruffilli I, Elia G, Ragusa F, Paparo SR, Patrizio A, Mazzi V, Varricchi G, Marone G, Antonelli A. Immune and Inflammatory Cells in Thyroid Cancer Microenvironment. Int J Mol Sci 2019;20:E4413. [PMID: 31500315 DOI: 10.3390/ijms20184413] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 13.7] [Reference Citation Analysis]
190 Azab B, Camacho-Rivera M, Taioli E. Average values and racial differences of neutrophil lymphocyte ratio among a nationally representative sample of United States subjects. PLoS One 2014;9:e112361. [PMID: 25375150 DOI: 10.1371/journal.pone.0112361] [Cited by in Crossref: 127] [Cited by in F6Publishing: 124] [Article Influence: 15.9] [Reference Citation Analysis]
191 Hu CH, Yeh CN, Chen JS, Tsai CY, Wang SY, Cheng CT, Yeh TS. Regorafenib treatment outcome for Taiwanese patients with metastatic gastrointestinal stromal tumors after failure of imatinib and sunitinib: A prospective, non-randomized, single-center study. Oncol Lett 2020;20:2131-42. [PMID: 32782530 DOI: 10.3892/ol.2020.11756] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
192 Utsumi M, Aoki H, Nagahisa S, Une Y, Kimura Y, Watanabe M, Taniguchi F, Arata T, Katsuda K, Tanakaya K. Nutritional assessment and surgical outcomes in very elderly patients undergoing pancreaticoduodenectomy: a retrospective study. Surg Today 2021;51:941-53. [PMID: 33106898 DOI: 10.1007/s00595-020-02169-2] [Reference Citation Analysis]
193 Azab B, Shah N, Radbel J, Tan P, Bhatt V, Vonfrolio S, Habeshy A, Picon A, Bloom S. Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients. Med Oncol 2013;30:432. [PMID: 23283648 DOI: 10.1007/s12032-012-0432-4] [Cited by in Crossref: 137] [Cited by in F6Publishing: 144] [Article Influence: 15.2] [Reference Citation Analysis]
194 Beltrán BE, Villela L, Torres MA, Otero V, Fiad L, Peña C, Cabrera ME, León P, Idrobo H, Castro DA, Paredes S, Perdomo I, Abello V, Rojas C, Ramirez-ibargüen A, Candelaria M, Pérez-jacobo F, Montaño-figueroa E, Best C, Goméz-de Leon A, Gómez-almaguer D, Ruiz-argüelles G, Hernández-hernández J, Malpica L, Sotomayor EM, Castillo JJ. A Multi-Institutional Validation of the Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients With Diffuse Large B-Cell Lymphoma: A Study From The Latin American Group of Lymphoproliferative Disorders (GELL). Clinical Lymphoma Myeloma and Leukemia 2020;20:637-46. [DOI: 10.1016/j.clml.2020.04.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
195 Yang JJ, Hu ZG, Shi WX, Deng T, He SQ, Yuan SG. Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: A meta-analysis. World J Gastroenterol 2015; 21(9): 2807-2815 [PMID: 25759553 DOI: 10.3748/wjg.v21.i9.2807] [Cited by in CrossRef: 97] [Cited by in F6Publishing: 98] [Article Influence: 13.9] [Reference Citation Analysis]
196 Mao YS, Hao SJ, Zou CF, Xie ZB, Fu DL. Controlling Nutritional Status score is superior to Prognostic Nutritional Index score in predicting survival and complications in pancreatic ductal adenocarcinoma: a Chinese propensity score matching study. Br J Nutr 2020;124:1190-7. [PMID: 32594921 DOI: 10.1017/S0007114520002299] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
197 Long Y, Zhang Y, Ni L, Yuan X, Liu Y, Tao J, Zhang Y. Prognostic value of platelet-to-lymphocyte ratio in neoadjuvant chemotherapy for solid tumors: A PRISMA-compliant meta-analysis. Medicine (Baltimore) 2021;100:e26202. [PMID: 34397999 DOI: 10.1097/MD.0000000000026202] [Reference Citation Analysis]
198 Ohno R, Kawamoto R, Kanamoto M, Watanabe J, Fujii M, Ohtani H, Harada M, Kumagi T, Kawasaki H. Neutrophil to Lymphocyte Ratio is a Predictive Factor of Malignant Potential for Intraductal Papillary Mucinous Neoplasms of the pancreas. Biomark Insights 2019;14:1177271919851505. [PMID: 31210727 DOI: 10.1177/1177271919851505] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
199 Xue W, Zhang X, Niu Z, Xin Z, Zhang H, Zhao Q, He J, Hu Z, Duan G. Neutrophil-Lymphocyte Ratio as a Predictive Factor of Growing Malignant Pulmonary Ground-glass Opacity. Cancer Manag Res 2021;13:5651-5. [PMID: 34285585 DOI: 10.2147/CMAR.S319190] [Reference Citation Analysis]
200 Mazzola A, Costantino A, Petta S, Bartolotta TV, Raineri M, Sacco R, Brancatelli G, Cammà C, Cabibbo G. Recurrence of hepatocellular carcinoma after liver transplantation: an update. Future Oncol 2015;11:2923-36. [PMID: 26414336 DOI: 10.2217/fon.15.239] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
201 Oshima M, Okano K, Suto H, Ando Y, Kamada H, Masaki T, Takahashi S, Shibata T, Suzuki Y. Changes and prognostic impact of inflammatory nutritional factors during neoadjuvant chemoradiotherapy for patients with resectable and borderline resectable pancreatic cancer. BMC Gastroenterol 2020;20:423. [PMID: 33317455 DOI: 10.1186/s12876-020-01566-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
202 Huang H, Wan X, Bai Y, Bian J, Xiong J, Xu Y, Sang X, Zhao H. Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of T stages in hilar cholangiocarcinoma. Cancer Manag Res. 2019;11:5157-5162. [PMID: 31239770 DOI: 10.2147/cmar.s192532] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
203 Zhang T, Jiang Y, Qu X, Shen H, Liu Q, Du J. Evaluation of preoperative hematologic markers as prognostic factors and establishment of novel risk stratification in resected pN0 non-small-cell lung cancer. PLoS One 2014;9:e111494. [PMID: 25360716 DOI: 10.1371/journal.pone.0111494] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
204 Yamada S, Fujii T, Yabusaki N, Murotani K, Iwata N, Kanda M, Tanaka C, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y. Clinical Implication of Inflammation-Based Prognostic Score in Pancreatic Cancer: Glasgow Prognostic Score Is the Most Reliable Parameter. Medicine (Baltimore) 2016;95:e3582. [PMID: 27149487 DOI: 10.1097/MD.0000000000003582] [Cited by in Crossref: 54] [Cited by in F6Publishing: 37] [Article Influence: 10.8] [Reference Citation Analysis]
205 Inoue D, Ozaka M, Matsuyama M, Yamada I, Takano K, Saiura A, Ishii H. Prognostic value of neutrophil-lymphocyte ratio and level of C-reactive protein in a large cohort of pancreatic cancer patients: a retrospective study in a single institute in Japan. Japanese Journal of Clinical Oncology 2014;45:61-6. [DOI: 10.1093/jjco/hyu159] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
206 Varricchi G, Loffredo S, Marone G, Modestino L, Fallahi P, Ferrari SM, de Paulis A, Antonelli A, Galdiero MR. The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition. Int J Mol Sci 2019;20:E3934. [PMID: 31412566 DOI: 10.3390/ijms20163934] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 9.7] [Reference Citation Analysis]
207 Serafini S, Friziero A, Sperti C, Vallese L, Grego A, Piangerelli A, Belluzzi A, Moletta L. The Ratio of C-Reactive Protein to Albumin Is an Independent Predictor of Malignant Intraductal Papillary Mucinous Neoplasms of the Pancreas. J Clin Med 2021;10:2058. [PMID: 34064877 DOI: 10.3390/jcm10102058] [Reference Citation Analysis]
208 Huang GQ, Zheng JN, Zou TT, Chen YR, Shi KQ, Poucke SV, Cheng Z, Ruan LY, Zheng MH. Stratified Platelet-to-lymphocyte Ratio: A Novel Target for Prognostic Prediction of Hepatocellular Carcinoma after Curative Liver Resection. J Clin Transl Hepatol 2017;5:35-42. [PMID: 28507925 DOI: 10.14218/JCTH.2016.00035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
209 Hamed MO, Roberts KJ, Smith AM, Morris Stiff G. Elevated pre-operative neutrophil to lymphocyte ratio predicts disease free survival following pancreatic resection for periampullary carcinomas. Pancreatology 2013;13:534-8. [PMID: 24075520 DOI: 10.1016/j.pan.2013.07.283] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
210 Huang H, Wang C, Ji F, Han Z, Xu H, Cao M. Nomogram based on albumin and neutrophil-to-lymphocyte ratio for predicting postoperative complications after pancreaticoduodenectomy. Gland Surg 2021;10:877-91. [PMID: 33842233 DOI: 10.21037/gs-20-789] [Reference Citation Analysis]
211 Chen Q, Dai Z, Yin D, Yang LX, Wang Z, Xiao YS, Fan J, Zhou J. Negative impact of preoperative platelet-lymphocyte ratio on outcome after hepatic resection for intrahepatic cholangiocarcinoma. Medicine (Baltimore). 2015;94:e574. [PMID: 25837750 DOI: 10.1097/md.0000000000000574] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 5.1] [Reference Citation Analysis]
212 Sevencan NO, Ozkan AE. Associations between neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, albuminuria and uric acid and the estimated glomerular filtration rate in hypertensive patients with chronic kidney disease stages 1-3. Arch Med Sci 2019;15:1232-9. [PMID: 31572468 DOI: 10.5114/aoms.2018.76262] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
213 Lee SH, Chung MJ, Kim B, Lee HS, Lee HJ, Heo JY, Kim YJ, Park JY, Bang S, Park SW, Song SY, Chung JB. The Significance of the Prognostic Nutritional Index for All Stages of Pancreatic Cancer. Nutrition and Cancer 2017;69:512-9. [DOI: 10.1080/01635581.2016.1250921] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
214 Pourafkari L, Wang CK, Tajlil A, Afshar AH, Schwartz M, Nader ND. platelet-lymphocyte ratio in prediction of outcome of acute heart failure. Biomark Med 2018;12:63-70. [PMID: 29172672 DOI: 10.2217/bmm-2017-0193] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
215 Morimoto M, Taniguchi K, Yamamoto O, Naka T, Sugitani A, Fujiwara Y. Preoperative white blood cell count predicts anastomotic leakage in patients with left-sided colorectal cancer. PLoS One 2021;16:e0258713. [PMID: 34669737 DOI: 10.1371/journal.pone.0258713] [Reference Citation Analysis]
216 Saskin H, Ozcan KS, Duzyol C, Baris O, Koçoğulları UC. Are inflammatory parameters predictors of amputation in acute arterial occlusions? Vascular 2017;25:170-7. [DOI: 10.1177/1708538116652995] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
217 Motomura T, Shirabe K, Mano Y, Muto J, Toshima T, Umemoto Y, Fukuhara T, Uchiyama H, Ikegami T, Yoshizumi T, Soejima Y, Maehara Y. Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment. J Hepatol. 2013;58:58-64. [PMID: 22925812 DOI: 10.1016/j.jhep.2012.08.017] [Cited by in Crossref: 219] [Cited by in F6Publishing: 241] [Article Influence: 21.9] [Reference Citation Analysis]
218 Schueneman AJ, Sugar EA, Uram J, Bigelow E, Herman JM, Edil BH, Jaffee EM, Zheng L, Laheru DA. Low total lymphocyte count is associated with poor survival in patients with resected pancreatic adenocarcinoma receiving a GM-CSF secreting pancreatic tumor vaccine. Ann Surg Oncol. 2013;20 Suppl 3:S725-S730. [PMID: 24046118 DOI: 10.1245/s10434-013-3262-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
219 Sharma K, Patel AK, Shah KH, Konat A. Is Neutrophil-to-Lymphocyte Ratio a Predictor of Coronary Artery Disease in Western Indians? Int J Inflam 2017;2017:4136126. [PMID: 28811954 DOI: 10.1155/2017/4136126] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
220 Kim Y, Kim YM, Kim JH, Youn YH, Kim JW, Park H. Peri-operative Inflammatory Marker as a Predictive Factor for Prolonged Post-operative Ileus After Gastrectomy for Gastric Cancer. J Neurogastroenterol Motil 2021;27:588-95. [PMID: 34642279 DOI: 10.5056/jnm20203] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
221 Zhou Y, Wei Q, Fan J, Cheng S, Ding W, Hua Z. Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: A meta-analysis containing 8252 patients. Clinica Chimica Acta 2018;479:181-9. [DOI: 10.1016/j.cca.2018.01.024] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 13.5] [Reference Citation Analysis]
222 Oylumlu M, Doğan A, Oylumlu M, Yıldız A, Yüksel M, Kayan F, Kilit C, Amasyalı B. Relationship between platelet-to-lymphocyte ratio and coronary slow flow. Anatol J Cardiol 2015;15:391-5. [PMID: 25430406 DOI: 10.5152/akd.2014.5376] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
223 Osayi SN, Bloomston M, Schmidt CM, Ellison EC, Muscarella P. Biomarkers as predictors of recurrence following curative resection for pancreatic ductal adenocarcinoma: a review. Biomed Res Int 2014;2014:468959. [PMID: 25050350 DOI: 10.1155/2014/468959] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
224 Wang YY, Bai ZL, He JL, Yang Y, Zhao R, Hai P, Zhe H. Prognostic Value of Neutrophil-Related Factors in Locally Advanced Cervical Squamous Cell Carcinoma Patients Treated with Cisplatin-Based Concurrent Chemoradiotherapy. Dis Markers 2016;2016:3740794. [PMID: 27087737 DOI: 10.1155/2016/3740794] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
225 Haider N, Mahmood Z, Khalid F, Razzak SA. Neutrophils to lymphocytes ratio between benign and malignant thyroid nodule. Pak J Med Sci 2021;37:1908-11. [PMID: 34912416 DOI: 10.12669/pjms.37.7.4503] [Reference Citation Analysis]